<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange Hibon</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://joseph.larmarange.net/spip.php?page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange Hibon</title>
		<url>https://joseph.larmarange.net/local/cache-vignettes/L144xH61/joseph_larmarange_hibon-df4da.png?1793811455</url>
		<link>https://joseph.larmarange.net/</link>
		<height>61</height>
		<width>144</width>
	</image>



<item xml:lang="fr">
		<title>Implementing HIV pre-exposure prophylaxis (PrEP) among cisgender female sex workers&#160;: A worldwide scoping review to guide the future research agenda for HIV prevention</title>
		<link>https://joseph.larmarange.net/implementing-hiv-pre-exposure</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/implementing-hiv-pre-exposure</guid>
		<dc:date>2026-11-15T11:54:40Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
M&#233;lanie Plazy, Valentine Becquet, Simon Amador-Paz, Marcellin Nouaman, Esther Maouhoub, Carla Meertens, Remi Mouquin, Hasna Youssoufa, Patrick Coffie, Joseph Larmarange &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Female sex workers (FSWs) experience a disproportionately high burden of HIV. To inform future research and policy efforts on HIV prevention, this study synthesizes global evidence on HIV pre-exposure prophylaxis (PrEP) among cisgender FSWs worldwide. This scoping review was conducted using six&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/IMG/logo/hand_-_pill.jpg.webp?1794743673' class='spip_logo spip_logo_right' width='150' height='84' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5864901&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05864901v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05864901v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Implementing HIV pre-exposure prophylaxis (PrEP) among cisgender female sex workers: A worldwide scoping review to guide the future research agenda for HIV prevention&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197956&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731632480&#034; class=&#034;hal-auteur&#034;&gt;Simon Amador-Paz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Esther+Maouhoub&#034; class=&#034;hal-auteur&#034;&gt;Esther Maouhoub&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Carla+Meertens&#034; class=&#034;hal-auteur&#034;&gt;Carla Meertens&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Remi+Mouquin&#034; class=&#034;hal-auteur&#034;&gt;Remi Mouquin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Hasna+Youssoufa&#034; class=&#034;hal-auteur&#034;&gt;Hasna Youssoufa&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;PLOS Global Public Health&lt;/i&gt;, 2026, 6 (11), pp.e0007582. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1371/journal.pgph.0007582&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1371/journal.pgph.0007582&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05864901v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05864901&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;M&#233;lanie Plazy, Valentine Becquet, Simon Amador-Paz, Marcellin Nouaman, Esther Maouhoub, Carla Meertens, Remi Mouquin, Hasna Youssoufa, Patrick Coffie, Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;Female sex workers (FSWs) experience a disproportionately high burden of HIV. To inform future research and policy efforts on HIV prevention, this study synthesizes global evidence on HIV pre-exposure prophylaxis (PrEP) among cisgender FSWs worldwide. This scoping review was conducted using six multidisciplinary databases searched up to December 2024. Titles and abstracts, then full texts, were independently screened. Data extraction comprised i) general study characteristics (UNAIDS region, country, study type, outcomes, type of PrEP, and study years), ii) detailed data of each outcome (including PrEP knowledge, a priori acceptability &#8211; interest, and effective acceptability &#8211; use, retention and adherence). Drivers and barriers to PrEP acceptability were analyzed using an adapted conceptual framework encompassing six domains&#160;: patient characteristics, individual knowledge and perceptions, medication-related factors, social processes, structural and health system factors, and sex work characteristics. After selection, 120 eligible studies were identified, mostly conducted in Eastern and Southern Africa. PrEP knowledge was initially low but increased quickly once programs were introduced. PrEP interest was consistently high across regions, driven by perceived HIV risk and desire for self&#8209;protection. PrEP uptake, retention and adherence varied widely. Main barriers included sex work realities (i.e., unstable housing, alcohol use), social processes (i.e., stigma), individual characteristics (i.e., mobility), treatment-related characteristics (i.e., side effects), and health system challenges (i.e., clinic access constraints). Drivers included social support and reminder tools. While evidence on long&#8209;acting PrEP remained limited, interest was consistently high as reducing daily burden. Overall, the findings support a socio-ecological understanding of PrEP engagement among FSWs, including the sex work context as a distinct intermediary layer. They highlight the need for differentiated and structurally responsive PrEP delivery models tailored to the realities of sex work. Expanding long&#8209;acting PrEP options and improving service accessibility, community engagement, and stigma reduction strategies will be critical to strengthening HIV prevention among FSWs globally.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Impact of HIV Pre-Exposure Prophylaxis on HIV Incidence and Hepatitis B Outcomes Among Sex Workers Living With Hepatitis B&#160;: A Modelling Analysis in C&#244;te D'Ivoire</title>
		<link>https://joseph.larmarange.net/impact-of-hiv-pre-exposure</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/impact-of-hiv-pre-exposure</guid>
		<dc:date>2026-11-14T14:27:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Amir M.&#160;Mohareb, Arthur Y. Kim, Menan G&#233;rard Kouam&#233;, Marcellin Nouaman, Patrick A. Coffie, Maya Hajny Fernandez, Virginia R. Talbot, Ruitian Xeno Hu, Anne M.&#160;Neilan, Anders Boyd, Kenneth A. Freedberg, Joseph Larmarange, Emily P. Hyle &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
Nearly 10% of sex workers in sub-Saharan Africa live with chronic hepatitis B virus (HBV). HIV pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (TDF/FTC) has not been studied in this population, possibly due to&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH86/hepatitis-std-liver-infection-with-hepatitis-viruses-l-3551199664-acd4b.jpg?1794752997' class='spip_logo spip_logo_right' width='150' height='86' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5865229&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05865229v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05865229v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Impact of HIV Pre&#8208;Exposure Prophylaxis on HIV Incidence and Hepatitis B Outcomes Among Sex Workers Living With Hepatitis B: A Modelling Analysis in C&#244;te D'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731360388&#034; class=&#034;hal-auteur&#034;&gt;Amir Mohareb&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Arthur+Kim&#034; class=&#034;hal-auteur&#034;&gt;Arthur Kim&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Menan+G%C3%A9rard+Kouam%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Menan G&#233;rard Kouam&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Maya+Hajny+Fernandez&#034; class=&#034;hal-auteur&#034;&gt;Maya Hajny Fernandez&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731751842&#034; class=&#034;hal-auteur&#034;&gt;Virginia Talbot&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ruitian+Xeno+Hu&#034; class=&#034;hal-auteur&#034;&gt;Ruitian Xeno Hu&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731677747&#034; class=&#034;hal-auteur&#034;&gt;Anne M Neilan&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/boyd0094&#034; class=&#034;hal-auteur&#034;&gt;Anders Boyd&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kenneth+Freedberg&#034; class=&#034;hal-auteur&#034;&gt;Kenneth Freedberg&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731360390&#034; class=&#034;hal-auteur&#034;&gt;Emily Hyle&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Journal of the International AIDS Society&lt;/i&gt;, 2026, 29 (10), &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1002/jia2.70217&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1002/jia2.70217&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05865229v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05865229&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Amir M.&#160;Mohareb, Arthur Y. Kim, Menan G&#233;rard Kouam&#233;, Marcellin Nouaman, Patrick A. Coffie, Maya Hajny Fernandez, Virginia R. Talbot, Ruitian Xeno Hu, Anne M.&#160;Neilan, Anders Boyd, Kenneth A. Freedberg, Joseph Larmarange, Emily P. Hyle&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Nearly 10% of sex workers in sub-Saharan Africa live with chronic hepatitis B virus (HBV). HIV pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (TDF/FTC) has not been studied in this population, possibly due to concerns of hepatitis flares following TDF/FTC cessation.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Using a microsimulation model of HIV and HBV disease and data from 2016 to 2024, we compared the clinical impact of TDF/FTC as PrEP versus no TDF/FTC among women who sell sex with HBV in C&#244;te d'Ivoire. We incorporated the anti-HBV effects of TDF/FTC and the increased probability of hepatitis flares and HBV surface antigen (HBsAg) loss following TDF/FTC cessation. We estimated input parameters from published literature&#160;: HIV incidence (1.9&#8211;3.0 per 100 person-years), PrEP adherence (55%), disengagement from PrEP care (4% per month for the first 12 months, then 12.5% per month), hepatitis flare incidence (2.0&#8722;4.0 per 100 person-years) and rate of HBsAg loss (1.0 per 100 person-years), which both increase following TDF/FTC cessation. Model outcomes included cumulative HIV incidence, average hepatitis flares, HBsAg loss and survival over 2, 5 and 10 years. We conducted sensitivity analyses varying HIV incidence, PrEP adherence, disengagement from PrEP care and hepatitis flare rate.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Compared with no TDF/FTC, TDF/FTC would reduce cumulative HIV incidence&#160;: 4.1% versus 5.6% at 2 years and 10.1% versus 12.7% at 5 years. TDF/FTC would result in more hepatitis flares (mean 0.76 vs. 0.19 per person) and more HBsAg loss (8.4% vs. 5.7%) than no TDF/FTC after 5 years. Two- and five-year survival would be similar between the two strategies, and TDF/FTC would improve survival over longer horizons. Improving adherence and reducing disengagement from care would increase clinical benefits. Even with high disengagement from care and high risk of hepatitis flares, TDF/FTC would reduce HIV acquisition and improve overall long-term survival.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Women who sell sex with HBV in C&#244;te d'Ivoire would benefit from TDF/FTC as PrEP to avoid HIV acquisition. The increased risk of hepatitis flares, while challenging to manage in resource-limited settings, would be outweighed by the benefits of HIV prevention. Efforts should be made to scale up PrEP in sex workers, including women with chronic HBV.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Cancers du sein au Mali&#160;: des diagnostics &#224; un stade avanc&#233;, associ&#233;s &#224; des indicateurs de pr&#233;carit&#233; </title>
		<link>https://joseph.larmarange.net/cancers-du-sein-au-mali-des</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/cancers-du-sein-au-mali-des</guid>
		<dc:date>2026-10-08T12:51:30Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>Mali</dc:subject>
		<dc:subject>SENOVIE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Cancer du sein</dc:subject>

		<description>
&lt;p&gt;Auteurs &lt;br class='autobr' /&gt;
Ad&#233;gn&#233; Togo, Cl&#233;mence Schantzs, Hamidou Niangaly, Ibrahim Terera, Julie Robin, Abdrahamane Kon&#233;, Madani Ly, Drissa Traore, Mamadou Sima, Ibrahima Teguet&#233;, Moussa Abdoulaye Ouattara, Issaka Sagara, Bakary Abou Traor&#233;, Luis Teixeira et Joseph Larmarange &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Introduction&#160;: Le cancer du sein est fr&#233;quent et souvent diagnostiqu&#233; &#224; un stade avanc&#233; au Mali. L'objectif de cette &#233;tude &#233;tait de d&#233;crire le stade au moment du diagnostic et d'identifier les facteurs associ&#233;s. M&#233;thodes&#160;:&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-senovie-171-+" rel="tag"&gt;SENOVIE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-cancer-du-sein-+" rel="tag"&gt;Cancer du sein&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH56/sans_titre-2-fad1f.png?1793198575' class='spip_logo spip_logo_right' width='150' height='56' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5786527&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05786483v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-a765f264-647a6.png?1793801673' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05786483v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Cancers du sein au Mali&#160;: des diagnostics &#224; un stade avanc&#233;, associ&#233;s &#224; des indicateurs de pr&#233;carit&#233;&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731686717&#034; class=&#034;hal-auteur&#034;&gt;Ad&#233;gn&#233; Togo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Hamidou+Niangaly&#034; class=&#034;hal-auteur&#034;&gt;Hamidou Niangaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ibrahim+Terera&#034; class=&#034;hal-auteur&#034;&gt;Ibrahim Terera&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Julie+Robin&#034; class=&#034;hal-auteur&#034;&gt;Julie Robin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Abdrahamane+Kon%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Abdrahamane Kon&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Madani+Ly&#034; class=&#034;hal-auteur&#034;&gt;Madani Ly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Drissa+Traore&#034; class=&#034;hal-auteur&#034;&gt;Drissa Traore&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mamadou+Sima&#034; class=&#034;hal-auteur&#034;&gt;Mamadou Sima&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ibrahima+Teguet%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Ibrahima Teguet&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Moussa+Abdoulaye+Ouattara&#034; class=&#034;hal-auteur&#034;&gt;Moussa Abdoulaye Ouattara&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/issaka-sagara&#034; class=&#034;hal-auteur&#034;&gt;Issaka Sagara&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Bakary+Abou+Traor%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Bakary Abou Traor&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Luis+Teixeira&#034; class=&#034;hal-auteur&#034;&gt;Luis Teixeira&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Sant&#233; Publique&lt;/i&gt;, 2026, 38 (3), pp.331-345. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.3917/spub.263.0331&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.3917/spub.263.0331&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05786483v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05786483&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;Ad&#233;gn&#233; Togo, Cl&#233;mence Schantzs, Hamidou Niangaly, Ibrahim Terera, Julie Robin, Abdrahamane Kon&#233;, Madani Ly, Drissa Traore, Mamadou Sima, Ibrahima Teguet&#233;, Moussa Abdoulaye Ouattara, Issaka Sagara, Bakary Abou Traor&#233;, Luis Teixeira et Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&#160;:&lt;/strong&gt; Le cancer du sein est fr&#233;quent et souvent diagnostiqu&#233; &#224; un stade avanc&#233; au Mali. L'objectif de cette &#233;tude &#233;tait de d&#233;crire le stade au moment du diagnostic et d'identifier les facteurs associ&#233;s.&lt;br class='autobr' /&gt;
M&#233;thodes&#160;: Dans le cadre du projet SENOVIE, une cohorte prospective multicentrique a &#233;t&#233; men&#233;e d'octobre 2023 &#224; octobre 2024 dans cinq &#233;tablissements de sant&#233; &#224; Bamako. Le stade clinique au diagnostic a &#233;t&#233; d&#233;fini selon la classification de l'UICC. Une analyse univariable a &#233;t&#233; r&#233;alis&#233;e, suivie d'une r&#233;gression logistique multinomiale multivariable.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats&#160;:&lt;/strong&gt; Au total, 265 patientes ont &#233;t&#233; incluses. Le diagnostic &#233;tait pr&#233;coce (stades I&#8211;II) chez 13,6&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% des patientes, tardif (stade III) chez 63,4&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;% et m&#233;tastatique (stade IV) chez 23,0&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;%.&lt;br class='autobr' /&gt;
En analyse univariable, le stade au diagnostic &#233;tait associ&#233; &#224; la r&#233;sidence hors de Bamako (p = 0,019), &#224; l'absence de scolarisation (p = 0,005), &#224; un faible niveau socio-&#233;conomique, &#224; l'absence d'assurance maladie (p = 0,012) et &#224; l'absence de t&#233;l&#233;vision (p = 0,042).&lt;/p&gt;
&lt;p&gt;En analyse multivariable, seul l'indice de masse corporelle restait significativement associ&#233; au stade au moment du diagnostic. Les patientes en surpoids &#233;taient plus souvent diagnostiqu&#233;es &#224; un stade pr&#233;coce (ORa = 2,99&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; IC95&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;%&#160;: 1,19&#8211;7,48), tandis que celles en situation d'ob&#233;sit&#233; &#233;taient moins fr&#233;quemment diagnostiqu&#233;es &#224; un stade m&#233;tastatique (ORa = 0,26&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; IC95&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;%&#160;: 0,12&#8211;0,60).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Discussion&#160;:&lt;/strong&gt; Ces r&#233;sultats confirment la fr&#233;quence &#233;lev&#233;e des diagnostics &#224; un stade avanc&#233; au Mali. Ils mettent en &#233;vidence l'influence de facteurs socio-&#233;conomiques et des parcours de soins dans le retard diagnostique.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&#160;:&lt;/strong&gt; Au Mali, le cancer du sein est majoritairement diagnostiqu&#233; &#224; un stade tardif. L'indice de masse corporelle est associ&#233; au stade au moment du diagnostic. Le renforcement du d&#233;pistage et de l'acc&#232;s aux soins appara&#238;t essentiel pour am&#233;liorer le diagnostic pr&#233;coce.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Mots-cl&#233;s &#233;diteurs&#160;:&lt;/strong&gt; cancers du sein, diagnostic tardif, pr&#233;carit&#233;, &#233;conomique et sociale, errance th&#233;rapeutique, Mali&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>La PrEP a r&#233;volutionn&#233; la pr&#233;vention du VIH. Mais cette avanc&#233;e b&#233;n&#233;ficie-t-elle r&#233;ellement &#224; toutes les populations&#160;?</title>
		<link>https://joseph.larmarange.net/la-prep-a-revolutionne-la</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/la-prep-a-revolutionne-la</guid>
		<dc:date>2026-08-03T13:38:41Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>

-
&lt;a href="https://joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L100xH150/pexels-leeloothefirst-20140040-a07a1.jpg?1793198577' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div style=&#034;text-align:center; margin: auto;&#034;&gt;&lt;iframe src=&#034;https://www.linkedin.com/embed/feed/update/urn:li:ugcPost:7485318050305515520&#034; height=&#034;1462&#034; width=&#034;540&#034; frameborder=&#034;0&#034; allowfullscreen=&#034;&#034; title=&#034;Post int&#233;gr&#233;&#034;&gt;&lt;/iframe&gt;&lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Participation au Congr&#232;s International sur la Sant&#233; des Femmes Africaines</title>
		<link>https://joseph.larmarange.net/participation-au-congres</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/participation-au-congres</guid>
		<dc:date>2026-07-15T10:21:06Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>SENOVIE</dc:subject>
		<dc:subject>Cancer du sein</dc:subject>
		<dc:subject>Femmes enceintes</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Sant&#233; des femmes</dc:subject>

		<description>
&lt;p&gt;En lien avec le projet SENOVIE &lt;br class='autobr' /&gt; In&#233;galit&#233;s socio&#233;conomiques li&#233;es &#224; l'acc&#232;s &#224; l'information sur les cancers du sein au Mali&#160;: une &#233;tude par m&#233;thodes mixtes &lt;br class='autobr' /&gt; Joseph Larmarange , Karna Coulibaly , Hamidou Niangaly , Julie Robin , Abdourahmane Coulibaly ,&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-senovie-171-+" rel="tag"&gt;SENOVIE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-cancer-du-sein-+" rel="tag"&gt;Cancer du sein&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Femmes-enceintes-+" rel="tag"&gt;Femmes enceintes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-sante-des-femmes-+" rel="tag"&gt;Sant&#233; des femmes&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L107xH150/affiche_cisfa_v2-eae7d.jpg?1793198581' class='spip_logo spip_logo_right' width='107' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
En lien avec le projet SENOVIE&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5693443&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05692476v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-fd94650b-aa17f.png?1793801674' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05692476v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;In&#233;galit&#233;s socio&#233;conomiques li&#233;es &#224; l'acc&#232;s &#224; l'information sur les cancers du sein au Mali : une &#233;tude par m&#233;thodes mixtes&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673977152&#034; class=&#034;hal-auteur&#034;&gt;Hamidou Niangaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/julie-robin&#034; class=&#034;hal-auteur&#034;&gt;Julie Robin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731290351&#034; class=&#034;hal-auteur&#034;&gt;Abdourahmane Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kadiatou+Kant%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Kadiatou Kant&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Solomane+Traor%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Solomane Traor&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ibrahim+T%C3%A9r%C3%A9ra&#034; class=&#034;hal-auteur&#034;&gt;Ibrahim T&#233;r&#233;ra&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/issaka-sagara&#034; class=&#034;hal-auteur&#034;&gt;Issaka Sagara&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;CISFA (Congr&#232;s international sur la sant&#233; des femmes africaines)&lt;/i&gt;, Jul 2026, Cotonou, B&#233;nin&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05692476v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05692476&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5692920&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05692920v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05692920v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Compl&#233;tude de la prise en charge du cancer du sein au Mali : impact de l'acc&#232;s &#224; l'immunohistochimie et &#224; la radioth&#233;rapie.&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731686717&#034; class=&#034;hal-auteur&#034;&gt;Ad&#233;gn&#233; Togo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673977152&#034; class=&#034;hal-auteur&#034;&gt;Hamidou Niangaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ibrahim+Terrera&#034; class=&#034;hal-auteur&#034;&gt;Ibrahim Terrera&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/julie-robin&#034; class=&#034;hal-auteur&#034;&gt;Julie Robin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Abdrahamane+Kone&#034; class=&#034;hal-auteur&#034;&gt;Abdrahamane Kone&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Madani+Ly&#034; class=&#034;hal-auteur&#034;&gt;Madani Ly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mamadou+Sima&#034; class=&#034;hal-auteur&#034;&gt;Mamadou Sima&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Moussa+Abdoulaye+Ouattara&#034; class=&#034;hal-auteur&#034;&gt;Moussa Abdoulaye Ouattara&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673758666&#034; class=&#034;hal-auteur&#034;&gt;Luis Teixeira&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;CISFA (Congr&#232;s international sur la sant&#233; des femmes africaines)&lt;/i&gt;, Jul 2026, Cotonou (B&#233;nin), B&#233;nin&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05692920v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05692920&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
En lien avec le projet PRINCESSE&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5693449&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05693165v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-94eeb15e-960f5.png?1793801674' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05693165v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Pr&#233;vention du VIH aupr&#232;s de femmes pr&#233;caires, mobiles et vuln&#233;rables en C&#244;te d'Ivoire : le&#231;ons du projet ANRS 12381 PRINCESSE aupr&#232;s de travailleuses du sexe&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673972362&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673950437&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;CISFA (Congr&#232;s international sur la sant&#233; des femmes africaines)&lt;/i&gt;, Jul 2026, Cotonou (B&#233;nin), B&#233;nin&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05693165v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05693165&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Synth&#232;se scientifique (c&#233;r&#233;monie de cl&#244;ture)&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5693436&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05693319v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-11e8f55b-f29eb.png?1793801675' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05693319v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Synth&#232;se scientifique de la premi&#232;re &#233;dition du Congr&#232;s International sur la Sant&#233; des Femmes Africaines (CISFA 2026)&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Congr&#232;s International sur la Sant&#233; des Femmes Africaines (CISFA)&lt;/i&gt;, Jul 2026, Cotonou, B&#233;nin&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05693319v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05693319&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;
&lt;p&gt;&lt;a href=&#034;https://www.ird.fr/premier-congres-international-sur-la-sante-des-femmes-en-afrique-un-succes-prometteur&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Plus d'informations dans les Actus de l'IRD&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/cisfa_2026_synthese_scientifique_larmarange.pdf" length="1278296" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>Pr&#233;sence &#224; l'AFRAVIH 2026</title>
		<link>https://joseph.larmarange.net/presence-a-l-afravih-2026</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/presence-a-l-afravih-2026</guid>
		<dc:date>2026-05-11T15:25:43Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>France</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>BESO</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>In&#233;galit&#233;s raciales</dc:subject>
		<dc:subject>Interdisciplinarit&#233;</dc:subject>
		<dc:subject>Intersectorialit&#233;</dc:subject>
		<dc:subject>Jeunes</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>&#201;ducation sexuelle</dc:subject>

		<description>
&lt;p&gt;13&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes, Lausanne, 4 au 7&#160;mai 2026, https://afravih2026.org. &lt;br class='autobr' /&gt; S'informer sur la sant&#233; sexualit&#233; et la sexualit&#233;&#160;: quelles donn&#233;es&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? comment les jeunes y acc&#232;dent-ils&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? quel acc&#232;s &#224; une &#233;ducation sexuelle compl&#232;te et compr&#233;hensive&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? &lt;br class='autobr' /&gt; Joseph Larmarange 13&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-beso-+" rel="tag"&gt;BESO&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-inegalites-raciales-+" rel="tag"&gt;In&#233;galit&#233;s raciales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-interdisciplinarite-+" rel="tag"&gt;Interdisciplinarit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-intersectorialite-+" rel="tag"&gt;Intersectorialit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Jeunes-+" rel="tag"&gt;Jeunes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-education-sexuelle-+" rel="tag"&gt;&#201;ducation sexuelle&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/IMG/logo/afravih-2026-scaled.webp?1778510599' class='spip_logo spip_logo_right' width='150' height='41' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;13&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes, Lausanne, 4 au 7&#160;mai 2026, &lt;a href=&#034;https://afravih2026.org&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://afravih2026.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619079&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619079v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619079v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;S'informer sur la sant&#233; sexualit&#233; et la sexualit&#233; : quelles donn&#233;es ? comment les jeunes y acc&#232;dent-ils ? quel acc&#232;s &#224; une &#233;ducation sexuelle compl&#232;te et compr&#233;hensive ?&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619079v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619079&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619120&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619112v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-1697f54f-033f0.png?1793801676' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619112v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;PrEP : perceptions et ressentis des potentiels utilisateurs&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619112v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619112&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
En lien avec le projet PRINCESSE&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619133&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619133v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619133v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Enjeux de la mise en &#339;uvre de la PrEP aupr&#232;s d'une population pr&#233;caire, mobile et vuln&#233;rable : le&#231;ons du projet ANRS 12381 PRINCESSE aupr&#232;s de travailleuses du sexe en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619133v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619133&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619143&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619143v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619143v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Facteurs de maintien et obstacles &#224; l'engagement des &#233;ducatrices de paires aupr&#232;s des travailleuses du sexe sur le projet ANRS 12381 PRINCESSE en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619143v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619143&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
En lien avec le projet BESO&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619157&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619157v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src=&#034;//thumb.ccsd.cnrs.fr/0/thumb&#034; alt=&#034;Image document&#034; width='150' height='350' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619157v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Repenser la mesure des pratiques pr&#233;ventives : l'exemple des besoins non couverts en sant&#233; sexuelle &#224; partir de l'enqu&#234;te CSF 2023&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619157v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619157&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Scaling Up HIV Self-Testing in Africa: Insights From National Programmatic Data in Eight Countries</title>
		<link>https://joseph.larmarange.net/scaling-up-hiv-self-testing-in</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/scaling-up-hiv-self-testing-in</guid>
		<dc:date>2026-04-29T18:06:11Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Kenya</dc:subject>
		<dc:subject>Lesotho</dc:subject>
		<dc:subject>Malawi</dc:subject>
		<dc:subject>Ouganda</dc:subject>
		<dc:subject>Tanzanie</dc:subject>
		<dc:subject>Mozambique</dc:subject>
		<dc:subject>Zimbabwe</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>Politiques publiques</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Adrien Allorant, Anne Bekelynck, Aliza Monroe-Wise, Carlota Baptista da Silva, Thato Chidarikire, Olanrewaju Edun, Leonid Joaquim, Christine Kisia, Joseph Larmarange, Johnson John Lyimo, Juma McOllogi James, Christine Musanhu, Getrude Ncube, Isabel Sathane, Arlette Simo-Fotso, Geoffrey Taasi, Cheryl Case Johnson &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
Evidence from routine, national programme data on HIV self-testing (HIVST) scale-up is limited. This study examines HIVST scale-up in eight&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Kenya-+" rel="tag"&gt;Kenya&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Lesotho-+" rel="tag"&gt;Lesotho&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Malawi-+" rel="tag"&gt;Malawi&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Ouganda-+" rel="tag"&gt;Ouganda&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Tanzanie-+" rel="tag"&gt;Tanzanie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-mozambique-+" rel="tag"&gt;Mozambique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-zimbabwe-+" rel="tag"&gt;Zimbabwe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Politiques-publiques-+" rel="tag"&gt;Politiques publiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH82/illustration-74655.png?1793198595' class='spip_logo spip_logo_right' width='150' height='82' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5607278&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05607277v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-499de955-317f3.png?1793801676' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05607277v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Scaling Up HIV Self&#8208;Testing in Africa: Insights From National Programmatic Data in Eight Countries&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731674953&#034; class=&#034;hal-auteur&#034;&gt;Adrien Allorant&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Anne+Bekelynck&#034; class=&#034;hal-auteur&#034;&gt;Anne Bekelynck&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aliza+Monroe-Wise&#034; class=&#034;hal-auteur&#034;&gt;Aliza Monroe-Wise&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Carlota+Baptista+da+Silva&#034; class=&#034;hal-auteur&#034;&gt;Carlota Baptista da Silva&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Thato+Chidarikire&#034; class=&#034;hal-auteur&#034;&gt;Thato Chidarikire&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731674954&#034; class=&#034;hal-auteur&#034;&gt;Olanrewaju Edun&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Leonid+Joaquim&#034; class=&#034;hal-auteur&#034;&gt;Leonid Joaquim&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Christine+Kisia&#034; class=&#034;hal-auteur&#034;&gt;Christine Kisia&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Johnson+John+Lyimo&#034; class=&#034;hal-auteur&#034;&gt;Johnson John Lyimo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Juma+Mcollogi+James&#034; class=&#034;hal-auteur&#034;&gt;Juma Mcollogi James&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Christine+Musanhu&#034; class=&#034;hal-auteur&#034;&gt;Christine Musanhu&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Getrude+Ncube&#034; class=&#034;hal-auteur&#034;&gt;Getrude Ncube&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Isabel+Sathane&#034; class=&#034;hal-auteur&#034;&gt;Isabel Sathane&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Arlette+Simo-Fotso&#034; class=&#034;hal-auteur&#034;&gt;Arlette Simo-Fotso&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Geoffrey+Taasi&#034; class=&#034;hal-auteur&#034;&gt;Geoffrey Taasi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197200&#034; class=&#034;hal-auteur&#034;&gt;Cheryl Johnson&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Journal of the International AIDS Society&lt;/i&gt;, 2026, 29 (5), pp.e70120. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1002/jia2.70120&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1002/jia2.70120&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05607277v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05607277&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Adrien Allorant, Anne Bekelynck, Aliza Monroe-Wise, Carlota Baptista da Silva, Thato Chidarikire, Olanrewaju Edun, Leonid Joaquim, Christine Kisia, Joseph Larmarange, Johnson John Lyimo, Juma McOllogi James, Christine Musanhu, Getrude Ncube, Isabel Sathane, Arlette Simo-Fotso, Geoffrey Taasi, Cheryl Case Johnson&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Evidence from routine, national programme data on HIV self-testing (HIVST) scale-up is limited. This study examines HIVST scale-up in eight African countries, describing how HIVST has been integrated into testing strategies and how testing coverage, test positivity, and linkage to antiretroviral therapy (ART) have evolved.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We conducted a retrospective descriptive analysis of national programme data from January 2019 to December 2023 across Kenya, Lesotho, Malawi, Mozambique, South Africa, Tanzania, Uganda and Zimbabwe. Data were disaggregated by quarter and subnational district. Indicators included HIVST kits distributed, conventional testing volumes, new HIV diagnoses and new ART initiations. We derived testing rates, testing positivity, ART linkage, and stability of HIVST distribution by district and over time.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;HIVST scale-up varied across countries. By the most recent quarter, HIVST accounted for 63% of total testing in Lesotho, 19%&#8211;25% in Malawi and Zimbabwe, but &lt;15% in Kenya, Tanzania, Uganda and South Africa. In Malawi, Lesotho and Zimbabwe, large volumes of HIVST partially offset declines in conventional testing during the COVID-19 pandemic. HIVST remained modest (&lt;15% of total tests) in Kenya and Tanzania. In Mozambique, both conventional testing and HIVST expanded. In South Africa, conventional testing remained high after COVID-19, while HIVST expanded slowly. Despite divergent trajectories, new HIV diagnoses and ART initiations remained stable in most settings, indicating programmes adapted to maintain case-finding even as testing volumes shifted.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;This descriptive analysis shows HIVST has been scaled to different degrees, with its contribution to overall testing shaped by national contexts, and distribution models. Interpretation is constrained by incomplete reporting, the inability to identify kits used out of kits distributed and distinguishing first-time from repeat testers. These findings can guide optimizing HIV testing services, an essential step towards meeting global HIV targets and ending AIDS by 2030.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>BESO - Besoins de pr&#233;vention en sant&#233; sexuelle non couverts selon l'origine&#160;: approche intersectionnelle et impact des discriminations</title>
		<link>https://joseph.larmarange.net/beso-besoins-de-prevention-en</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/beso-besoins-de-prevention-en</guid>
		<dc:date>2026-03-01T16:08:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>France</dc:subject>
		<dc:subject>BESO</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>Intersectorialit&#233;</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Pr&#233;carit&#233;</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>In&#233;galit&#233;s raciales</dc:subject>
		<dc:subject>Discriminations / Stigmatisation</dc:subject>

		<description>
&lt;p&gt;Responsable scientifique COULIBALY Karna &lt;br class='autobr' /&gt;
Membres du Ceped participant au projet COULIBALY Karna (Post-doctorants et Jeunes chercheurs) LARMARANGE Joseph (Chercheurs, Enseignants-Chercheurs, Ing&#233;nieurs) &lt;br class='autobr' /&gt;
Financements ANRS | MIE LIEPP Sciences Po - IdEx Universit&#233; Paris Cit&#233; (ANR-18-IDEX-0001) &lt;br class='autobr' /&gt;
Partenaires Centre Population et D&#233;veloppement Institut national de la sant&#233; et de la recherche m&#233;dicale (Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; http://www.inserm.fr &#201;quipe de l'enqu&#234;te Contexte des sexualit&#233;s en France (CSF&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-beso-+" rel="tag"&gt;BESO&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-intersectorialite-+" rel="tag"&gt;Intersectorialit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Precarite-+" rel="tag"&gt;Pr&#233;carit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-inegalites-raciales-+" rel="tag"&gt;In&#233;galit&#233;s raciales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-discriminations-stigmatisation-+" rel="tag"&gt;Discriminations / Stigmatisation&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH82/gemini_generated_image_4sp0ot4sp0ot4sp0-08186.png?1793198597' class='spip_logo spip_logo_right' width='150' height='82' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsable scientifique&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; COULIBALY Karna&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Membres du Ceped participant au projet&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; COULIBALY Karna (Post-doctorants et Jeunes chercheurs)&lt;/li&gt;&lt;li&gt; LARMARANGE Joseph (Chercheurs, Enseignants-Chercheurs, Ing&#233;nieurs)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financements&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; ANRS | MIE&lt;/li&gt;&lt;li&gt; LIEPP Sciences Po - IdEx Universit&#233; Paris Cit&#233; (ANR-18-IDEX-0001)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenaires&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Centre Population et D&#233;veloppement&lt;/li&gt;&lt;li&gt; Institut national de la sant&#233; et de la recherche m&#233;dicale (Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;http://www.inserm.fr&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;http://www.inserm.fr&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &#201;quipe de l'enqu&#234;te Contexte des sexualit&#233;s en France (CSF 2023)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233; &lt;/h2&gt;
&lt;p&gt;Les derni&#232;res d&#233;cennies ont &#233;t&#233; marqu&#233;es par d'importants progr&#232;s en mati&#232;re de prise en charge et de pr&#233;vention des probl&#233;matiques de sant&#233; sexuelle. L'offre de pr&#233;vention du VIH, des IST et des grossesses non souhait&#233;es s'est diversifi&#233;e afin de r&#233;pondre aux diff&#233;rents besoins de pr&#233;vention des personnes expos&#233;es. Cependant, les donn&#233;es &#233;pid&#233;miologiques r&#233;v&#232;lent la persistance de nouvelles infections par le VIH, des IST bact&#233;riennes ainsi que des cas de grossesses non souhait&#233;es.&lt;/p&gt;
&lt;p&gt;Ces constats soulignent l'existence de besoins de pr&#233;vention en sant&#233; sexuelle non couverts c'est-&#224;-dire le fait d'&#234;tre expos&#233; &#224; des risques en sant&#233; sexuelle sans recourir aux m&#233;thodes de pr&#233;vention disponibles. La question des besoins de pr&#233;vention en sant&#233; sexuelle non couverts constitue ainsi un enjeu majeur de pr&#233;vention en sant&#233; sexuelle. Cependant, sa mesure reste complexe. D'une part, parce qu'elle suppose de pouvoir identifier les expositions en sant&#233; sexuelle au niveau individuel et les m&#233;thodes adapt&#233;es &#224; chaque exposition. Or, les diff&#233;rents outils de pr&#233;vention ne prot&#232;gent pas tous des m&#234;mes risques et tous les individus n'ont pas forc&#233;ment un besoin pr&#233;ventif. D'autre part, sa mesure exige de disposer de donn&#233;es de grande ampleur qui portent sur toutes les populations, qui couvrent les expositions et interrogent le recours aux m&#233;thodes pr&#233;ventives. Ce type d'enqu&#234;te est pourtant rare en France. Ce projet de recherche a pour objectif principal d'&#233;tudier &#224; partir des donn&#233;es de l'enqu&#234;te Contexte des Sexualit&#233;s en France (CSF 2023), une enqu&#234;te nationale repr&#233;sentative des populations de 15 &#224; 89 ans vivant en France &#8211; comment mesurer les besoins de pr&#233;vention en sant&#233; sexuelle non couverts&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Cette r&#233;flexion est abord&#233;e &#224; partir des besoins de pr&#233;vention non couverts li&#233;s au VIH, aux IST bact&#233;riennes et aux grossesses non souhait&#233;es. Ce projet vise des comparaisons selon l'origine pour mettre en lumi&#232;re les in&#233;galit&#233;s en sant&#233; sexuelle qui existent entre les populations selon leur origine et &#233;tudier leurs d&#233;terminants. &lt;br class='autobr' /&gt;
Ce projet vise &#224;&#160;:&lt;/p&gt;
&lt;ol class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; d&#233;finir comment mesurer les besoins de pr&#233;vention en sant&#233; sexuelle non-couverts (VIH, IST bact&#233;riennes et grossesses non souhait&#233;es),&lt;/li&gt;&lt;li&gt; construire des indicateurs de mesure des besoins pr&#233;ventifs&#160;: absence de besoins, besoins couverts (et m&#233;thodes utilis&#233;es), besoins non couverts et analyser les diff&#233;rences de besoins de pr&#233;vention en sant&#233; sexuelle non couverts selon l'origine,&lt;/li&gt;&lt;li&gt; v&#233;rifier si les &#233;carts de besoins de pr&#233;vention en sant&#233; sexuelle non couverts selon l'origine se maintiennent apr&#232;s avoir pris en compte l'imbrication des rapports sociaux de genre, classe, race, d'orientation sexuelle&#8230;(approche bas&#233;e sur l'intersectionnalit&#233;),&lt;/li&gt;&lt;li&gt; examiner dans quelle mesure l'effet de l'origine sur les besoins de pr&#233;vention en sant&#233; sexuelle non couverts est m&#233;di&#233; par les discriminations subies. Cette recherche contribuera au d&#233;veloppement de nouvelles connaissances sur les besoins de pr&#233;vention de la population majoritaire, des immigr&#233;s, des descendants d'immigr&#233;s et des natifs des DOM.&#160;Elle permettra d'&#233;tudier les liens complexes entre origine, intersectionnalit&#233;, discrimination et besoins de pr&#233;vention en sant&#233; sexuelle.&lt;/li&gt;&lt;/ol&gt;&lt;h2 class=&#034;spip&#034;&gt;
Mots-Cl&#233;s &lt;/h2&gt;
&lt;p&gt;Sant&#233; Sexuelle, Besoins non couverts, Pr&#233;vention, VIH, IST, Grossesses non souhait&#233;es, Origine, Intersectionnalit&#233;, Discriminations.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Zones g&#233;ographiques (terrains de recherche)&lt;/h2&gt;
&lt;p&gt;France hexagonale et Outre-Mer&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2025 - 2027&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>&#201;couter les paires &#233;ducatrices&#160;: la force du savoir exp&#233;rientiel Les paires &#233;ducatrices jouent </title>
		<link>https://joseph.larmarange.net/ecouter-les-paires-educatrices-la</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/ecouter-les-paires-educatrices-la</guid>
		<dc:date>2026-02-11T11:05:50Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Paires-&#233;ducatrices &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; Pairs-&#233;ducateurs</dc:subject>

		<description>
&lt;p&gt;Joseph Larmarange &#233;change avec les paires &#233;ducatrices du projet PRINCESSE en C&#244;te d'Ivoire sur les difficult&#233;s de terrain dans la mise en &#339;uvre. &lt;br class='autobr' /&gt; Ici, je discute avec une partie des douze paires &#233;ducatrices du projet Princesse, lors d'un atelier de r&#233;flexion collective. Hors champ se trouve le reste de l'&#233;quipe scientifique qui participe &#233;galement &#224; cet &#233;change. Et derri&#232;re nous, un mur couvert de post-it&#160;: bleu pour ce qui fonctionne, rose pour ce qui coince, jaune pour ce qu'il faut&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-paires-educatrices-pairs-+" rel="tag"&gt;Paires-&#233;ducatrices &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; Pairs-&#233;ducateurs&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH56/img-20230119-wa0003-e85a4.png?1793198597' class='spip_logo spip_logo_right' width='150' height='56' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Joseph Larmarange &#233;change avec les paires &#233;ducatrices du projet PRINCESSE en C&#244;te d'Ivoire sur les difficult&#233;s de terrain dans la mise en &#339;uvre.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;Ici, je discute avec une partie des douze paires &#233;ducatrices du projet Princesse, lors d'un atelier de r&#233;flexion collective. Hors champ se trouve le reste de l'&#233;quipe scientifique qui participe &#233;galement &#224; cet &#233;change. Et derri&#232;re nous, un mur couvert de post-it&#160;: bleu pour ce qui fonctionne, rose pour ce qui coince, jaune pour ce qu'il faut am&#233;liorer. Ce sont leurs mots, leurs exp&#233;riences, leurs analyses critiques, et c'est pr&#233;cis&#233;ment pour cela qu'ils comptent.&lt;/p&gt;
&lt;p&gt;Le projet Princesse s'appuyait sur une clinique mobile de sant&#233; sexuelle qui se d&#233;pla&#231;ait directement sur les sites de prostitution de la r&#233;gion de San-Pedro, en C&#244;te d'Ivoire. Pour le mener &#224; bien, nous avons collabor&#233; avec l'ONG Aprosam et une &#233;quipe m&#234;lant m&#233;decins, biologistes, assistantes sociales&#8230; et paires &#233;ducatrices. Ces derni&#232;res ne sont pas de simples b&#233;n&#233;ficiaires&#160;: elles viennent de la communaut&#233; concern&#233;e et en sont des actrices essentielles. Elles connaissent les r&#233;alit&#233;s du terrain mieux que quiconque, et leurs retours compl&#232;tent ce que nous, chercheurs et soignants, ne percevons pas toujours.&lt;/p&gt;
&lt;p&gt;Leur r&#244;le est d&#233;terminant&#160;: elles recrutent les participantes, les sensibilisent &#224; des outils comme la PrEP orale, les mobilisent pour qu'elles se rendent au camion Princesse et assurent un suivi afin que leur parcours de soins s'inscrive dans la dur&#233;e. Elles nous expliquent aussi, lors d'ateliers comme celui-ci, les obstacles &#224; l'adh&#233;sion au projet ou &#224; la PrEP orale, ce qui est indispensable. En effet, en tant que scientifiques, nous sommes souvent convaincus de la pertinence des solutions propos&#233;es. Mais seule la r&#233;alit&#233; de terrain nous permet de r&#233;aliser que leur adoption n'a rien d'automatique. Le savoir exp&#233;rientiel des paires &#233;ducatrices est alors pr&#233;cieux et essentiels pour mieux comprendre les logiques &#224; l'&#339;uvre.&lt;/p&gt;
&lt;p&gt;C'est gr&#226;ce &#224; elles, par exemple, que nous avons compris pourquoi la prise de PrEP orale n'est pas si simple&#160;: ce n'est pas toujours la priorit&#233; des participantes, qui doivent d'abord, dans un contexte de forte pr&#233;carit&#233;, g&#233;rer d'autres priorit&#233;s quotidiennes. Les contraintes concr&#232;tes de l'offre de pr&#233;vention ne contrebalancent pas forc&#233;ment un b&#233;n&#233;fice plus &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;th&#233;oriques&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;.&lt;/p&gt;
&lt;p&gt;Les retours des paires-&#233;ducatrices nous ont permis d'ajuster l'offre de soins. Par exemple, elles nous ont alert&#233;s sur des aspects tr&#232;s concrets, comme la n&#233;cessit&#233; d'offrir une collation apr&#232;s les consultations comportant de nombreuses prises de sang. Nous pensions qu'un acc&#232;s gratuit aux examens et aux soins suffirait, mais certaines femmes avaient le sentiment d'&#234;tre flou&#233;es&#160;: lorsqu'elles donnent leur sang ailleurs, on leur offre toujours quelque chose &#224; boire ou &#224; manger. Un d&#233;tail simple, pourtant essentiel. D'autres ateliers ont enfin permis de repenser les horaires, de d&#233;placer certains sites d'intervention ou de r&#233;organiser des &#233;tapes du parcours de soins.&lt;/p&gt;
&lt;p&gt;Obtenir des retours sinc&#232;res n'a cependant pas &#233;t&#233; imm&#233;diat. Le contexte joue un r&#244;le important&#160;: les messages des bailleurs p&#232;sent fortement sur les programmes, et le rapport de domination entre savoir scientifique reconnu et savoir exp&#233;rientiel des paires &#233;ducatrices ne doit pas &#234;tre n&#233;glig&#233;. Il nous a alors fallu du temps pour instaurer une relation de confiance, un espace o&#249; les paires &#233;ducatrices se sentent l&#233;gitimes pour d&#233;passer les discours attendus et exprimer leur v&#233;ritable opinion. Nos ateliers en commun ont &#233;t&#233; peu productifs au d&#233;part, mais absolument n&#233;cessaires pour la suite.&lt;/p&gt;
&lt;p&gt;Et la suite, c'est un travail de coconstruction des interventions, o&#249; savoir scientifique et savoir exp&#233;rientiel se r&#233;pondent pour identifier les leviers et les freins &#224; l'adoption de nouveaux outils, et adapter les solutions au mieux. Les communaut&#233;s connaissent leur terrain mieux que nous, chercheurs, qui ne sommes pas sur place en permanence. &#201;couter les premi&#232;res concern&#233;es est donc indispensable. L'empouvoirement prend du temps, mais rien ne peut se faire sans les paires &#233;ducatrices. Leur parole est notre boussole.&lt;/p&gt;
&lt;p&gt;Un grand merci aux paires &#233;ducatrices du projet Princesse&#160;: C&#233;c&#233;, Chef d'&#233;tat-major, Dodo, Flore, Francas, Kiki, Mama Kate, Merveille, Miss Falone, Nemy, Roky et Sly.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Auteur&#160;:&lt;/strong&gt; Louise Hurel &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;strong&gt;Photo&#160;:&lt;/strong&gt; projet PRINCESSE&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;POUR ALLER PLUS LOIN&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Les le&#231;ons du projet PRINCESSE racont&#233;es par les paires-&#233;ducatrices, l'&#233;quipe soignante et l'&#233;quipe scientifique du projet&#160;:&lt;/p&gt;
&lt;div class=&#034;spip_document_ spip_document spip_documents spip_document_video ressource oembed oembed_video oembed_video oembed_youtube&#034; &gt; &lt;figure class=&#034;spip_doc_inner&#034;&gt; &lt;div class=&#034;oembed oe-video async clearfix&#034; style=&#034;max-width:800px;&#034;&gt; &lt;div class=&#034;rwd-video-container oe-play-button&#034; style=&#034;width:100%;height:0;padding-bottom:56.25%;background-image:url('https://i.ytimg.com/vi/Wy6TdjTfSiE/hqdefault.jpg');background-repeat:no-repeat;background-position:center;background-size:cover;&#034; data-content=&#034;%3Ciframe%20width%3D%22800%22%20height%3D%22450%22%20src%3D%22https%3A%2F%2Fwww.youtube-nocookie.com%2Fembed%2FWy6TdjTfSiE%3Ffeature%3Doembed%26autoplay%3D1%22%20frameborder%3D%220%22%20allow%3D%22accelerometer%3B%20autoplay%3B%20clipboard-write%3B%20encrypted-media%3B%20gyroscope%3B%20picture-in-picture%3B%20web-share%22%20referrerpolicy%3D%22strict-origin-when-cross-origin%22%20allowfullscreen%20title%3D%22Le%C3%A7ons%20apprises%20du%20projet%20ANRS%2012381%20PRINCESSE%20en%20C%C3%B4te%20d%E2%80%99Ivoire%22%3E%3C%2Fiframe%3E&#034;&gt; &lt;button&gt;&lt;span class=&#034;oe-play-button_label&#034;&gt;Lecture&lt;/span&gt;&lt;/button&gt; &lt;/div&gt; &lt;style&gt;&lt;!--/**/.oe-video .loading {background-image:url(&#034;prive/themes/spip/images/searching.gif&#034;)!important;background-size:auto !important;}/**/--&gt;&lt;/style&gt;
&lt;/div&gt; &lt;figcaption class=&#034;spip_doc_legende&#034;&gt;
&lt;div class=&#034;spip_doc_titre&#034; style=&#034;max-width:800px;&#034;&gt;&lt;a href=&#034;https://youtu.be/Wy6TdjTfSiE&#034; class=&#034;oe-title&#034;&gt;Le&#231;ons apprises du projet ANRS 12381 PRINCESSE en C&#244;te d'Ivoire&lt;/a&gt; &lt;span class=&#034;oe-author&#034;&gt;&lt;br/&gt;&lt;span class=&#034;oe-author_par&#034;&gt;par &lt;/span&gt;&lt;a href=&#034;https://www.youtube.com/@Ceped&#034; class=&#034;oe-author_name&#034;&gt;Ceped - Centre Population &amp; D&#233;veloppement&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&#034;spip_doc_titre oembed-source&#034;&gt;&lt;a href=&#034;https://youtu.be/Wy6TdjTfSiE&#034; class=&#034;spip_url spip_out&#034; rel=&#034;external&#034;&gt;https://youtu.be/Wy6TdjTfSiE&lt;/a&gt;
&lt;/div&gt;
&lt;/figcaption&gt; &lt;script&gt;jQuery(function(){ jQuery('.oembed.oe-video.async').not('.done').addClass('done').on('click', '.oe-play-button',function(e){var $me = jQuery(this),content = decodeURIComponent($me.data('content'));$me.removeClass('oe-play-button').addClass('loading').html(content);})})&lt;/script&gt; &lt;/figure&gt;
&lt;/div&gt;
&lt;p&gt;&lt;strong&gt;ANNEXE&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Le projet PRINCESSE a &#233;t&#233; financ&#233; par l'ANRS|MIE. Il a &#233;t&#233; coordonn&#233; par le programme PAC-CI en C&#244;te d'Ivoire et l'IRD en France et a impliqu&#233; de nombreux partenaires institutionnels. Plus d'informations sur &lt;a href=&#034;https://www.ceped.org/princesse&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://www.ceped.org/princesse&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Comparing modelled HIV incidence estimates with empirical HIV incidence observations in high-burden HIV African epidemic settings: systematic review and meta-regression</title>
		<link>https://joseph.larmarange.net/comparing-modelled-hiv-incidence</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/comparing-modelled-hiv-incidence</guid>
		<dc:date>2026-02-10T17:15:53Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE&#160;HIBON</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Oliver Stevens, Michelle Moffa, Joanne H. Hunt, Kyle Patel, Tihitna Aytenfisu, Adam Akullian, Rebecca L Anderson, Peter Bock, Amelia C Crampin, Sian Floyd, Simon Gregson, Richard J Hayes, Collins Iwuji, Ivan Kasamba, Daniel Kwaro, Joseph Larmarange, Shahin Lockman, Denna Michael, Louisa Moorhouse, Joseph Mugisha, Elphas Okango, Maya L Petersen, Victor Ssempijja, Emma Slaymaker, Frank Tanser, Cari van Schalkwyk, M. Kate Grabowski, Jeffrey W. Imai-Eaton &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
HIV&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH112/21c2fcee-4d67-40a5-86ac-45a0f0482045-abbe7.jpg?1793198597' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5503917&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05503914v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-6fdcce37-0f350.png?1793801672' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05503914v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Comparing modelled HIV incidence estimates with empirical HIV incidence observations in high-burden HIV African epidemic settings: systematic review and meta-regression&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731644810&#034; class=&#034;hal-auteur&#034;&gt;Oliver Stevens&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Michelle+Moffa&#034; class=&#034;hal-auteur&#034;&gt;Michelle Moffa&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Joanne+Hunt&#034; class=&#034;hal-auteur&#034;&gt;Joanne Hunt&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kyle+Patel&#034; class=&#034;hal-auteur&#034;&gt;Kyle Patel&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Tihitna+Aytenfisu&#034; class=&#034;hal-auteur&#034;&gt;Tihitna Aytenfisu&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Adam+Akullian&#034; class=&#034;hal-auteur&#034;&gt;Adam Akullian&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731644811&#034; class=&#034;hal-auteur&#034;&gt;Rebecca Anderson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Peter+Bock&#034; class=&#034;hal-auteur&#034;&gt;Peter Bock&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Amelia+Crampin&#034; class=&#034;hal-auteur&#034;&gt;Amelia Crampin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Sian+Floyd&#034; class=&#034;hal-auteur&#034;&gt;Sian Floyd&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Simon+Gregson&#034; class=&#034;hal-auteur&#034;&gt;Simon Gregson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Richard+Hayes&#034; class=&#034;hal-auteur&#034;&gt;Richard Hayes&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Collins+Iwuji&#034; class=&#034;hal-auteur&#034;&gt;Collins Iwuji&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ivan+Kasamba&#034; class=&#034;hal-auteur&#034;&gt;Ivan Kasamba&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Daniel+Kwaro&#034; class=&#034;hal-auteur&#034;&gt;Daniel Kwaro&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Shahin+Lockman&#034; class=&#034;hal-auteur&#034;&gt;Shahin Lockman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Denna+Michael&#034; class=&#034;hal-auteur&#034;&gt;Denna Michael&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731644812&#034; class=&#034;hal-auteur&#034;&gt;Louisa Moorhouse&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Joseph+Mugisha&#034; class=&#034;hal-auteur&#034;&gt;Joseph Mugisha&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Elphas+Okango&#034; class=&#034;hal-auteur&#034;&gt;Elphas Okango&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Maya+Petersen&#034; class=&#034;hal-auteur&#034;&gt;Maya Petersen&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Victor+Ssempijja&#034; class=&#034;hal-auteur&#034;&gt;Victor Ssempijja&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Emma+Slaymaker&#034; class=&#034;hal-auteur&#034;&gt;Emma Slaymaker&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Frank+Tanser&#034; class=&#034;hal-auteur&#034;&gt;Frank Tanser&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cari+van+Schalkwyk&#034; class=&#034;hal-auteur&#034;&gt;Cari van Schalkwyk&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=M.+Kate+Grabowski&#034; class=&#034;hal-auteur&#034;&gt;M. Kate Grabowski&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Jeffrey+Imai-Eaton&#034; class=&#034;hal-auteur&#034;&gt;Jeffrey Imai-Eaton&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2026&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-undefined&#034;&gt;Pr&#233;-publication, Document de travail&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05503914v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05503914&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Oliver Stevens, Michelle Moffa, Joanne H. Hunt, Kyle Patel, Tihitna Aytenfisu, Adam Akullian, Rebecca L Anderson, Peter Bock, Amelia C Crampin, Sian Floyd, Simon Gregson, Richard J Hayes, Collins Iwuji, Ivan Kasamba, Daniel Kwaro, Joseph Larmarange, Shahin Lockman, Denna Michael, Louisa Moorhouse, Joseph Mugisha, Elphas Okango, Maya L Petersen, Victor Ssempijja, Emma Slaymaker, Frank Tanser, Cari van Schalkwyk, M. Kate Grabowski, Jeffrey W. Imai-Eaton&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;HIV incidence in sub-Saharan Africa has declined substantially since 2000 according to epidemic estimates published by UNAIDS. These estimates, derived by fitting mathematical models to national surveillance data, guide HIV programmes and epidemic response strategies. We assessed whether the level and age distribution of HIV incidence from modelled estimates were consistent with empirical HIV incidence observations, and whether incidence levels and trends were systematically different between study types, populations, and age groups.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We conducted an updated systematic review of adult HIV incidence data from sub-Saharan Africa published July 2019-February 2024 by searching Scopus, PubMed, Embase, and OVID databases, and combined with earlier systematic review data. We matched empirical incidence measurements between 1990-2023 to UNAIDS HIV incidence estimates by study area, sex, age group, and year. We used Bayesian mixed-effect Poisson regression to estimate (1) incidence rate ratios (IRR) between empirical observations and matched modelled incidence estimates adjusted for sex, year and study type/population; and (2) time trends in age-specific incidence from population-based cohort studies and household surveys.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;3560 HIV empirical incidence measurements were included from 179 studies conducted in 21 countries, comprising 23,000 new infections and 3.1 million person-years. Incidence observations from nationally-representative household surveys (IRR 1.07 95%CI 0.68, 1.67) and population-representative study populations (IRR 0.98 95%CI 0.51, 1.89) were not significantly different from matched modelled estimates, and declined at the same rate as modelled estimates (annual aRR 0.99 95%CI 0.98, 1.01). Studies among pregnant women (IRR 2.60 95%CI 1.58, 4.28), control arms of clinical trials (IRR 3.01 95%CI 1.90, 4.77) and key populations (FSW IRR: 6.46 95%CI 4.18, 10.00; MSM 44.02 95%CI 27.35, 70.87) had significantly higher incidence than modelled total population incidence estimates. Across population cohorts in Eastern and Southern Africa, HIV incidence among adults aged 15-49 declined by 75-90% between 2010-2023, and declined 7% (95%CI 4-10%) faster per year among young adults 15-24 compared to age 25+ years. Modelled incidence declined similarly to cohort data, but did not reflect the aging of the epidemic.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Observed incidence in population-representative studies in sub-Saharan Africa has declined steeply. Mathematical models that infer incidence from cross-sectional HIV surveillance data estimated the same incidence level and decline over time as population-representative studies. Studies with non-representative inclusion criteria had significantly higher incidence, including those among pregnant women and most HIV prevention/vaccine efficacy trials. The age pattern of incidence in modelled estimates should be reconsidered to capture the aging of the epidemic indicated by cohort studies.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>



</channel>

</rss>
